Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications
Psychometric evaluation of the NFOSI-18 disease related symptoms - Physical, NFOSI-18 Total, and FACT GP5 in the recurrent ovarian cancer phase III study GY004.
Journal: Gynecologic oncology
Published: April 12, 2026
Incidence and clinical features of cataracts: an under-recognized adverse event with mirvetuximab soravtansine-gynx in ovarian cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 18, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 26, 2025
Erratum: Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 14, 2025
ASCO neoadjuvant chemotherapy in ovarian cancer guideline: A SGO endorsement.
Journal: Gynecologic oncology
Published: October 14, 2025
A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancer.
Journal: Gynecologic oncology
Published: August 01, 2025
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
Journal: Gynecologic oncology
Published: April 17, 2025
Understanding frailty and the role of patient-centered care for older adults with gynecologic cancer.
Journal: Gynecologic oncology
Published: February 05, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate.
Journal: Gynecologic oncology
Published: January 27, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Clinical Insights.
Journal: JCO oncology practice
Published: January 22, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 22, 2025
Association between genomic instability score and progression-free/overall survival in patients with newly diagnosed non-BRCA1/2 ovarian cancer.
Journal: Gynecologic oncology
Published: September 17, 2024
Last Updated: 09/26/2026